相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
Comprehensive analysis of FOXP3 mRNA expression in leukemia and transformed cell lines
Mayuko Yamamoto et al.
LEUKEMIA RESEARCH (2008)
Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3
N. Booken et al.
LEUKEMIA (2008)
FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with stage and survival
L. M. Gjerdrum et al.
LEUKEMIA (2007)
Chemokine receptor expression by leukemic T cells of cutaneous T-cell lymphoma: Clinical and histopathological correlations
Elisabetta Capriotti et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Induction of FOXP3 expression in naive human CD4+FOXP3- T cells by T-cell receptor stimulation is transforming growth factor-β-dependent but does not confer a regulatory phenotype
Dat Q. Tran et al.
BLOOD (2007)
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+functional regulatory T-cells in patients with graft-versus-host disease
Ettore Biagi et al.
TRANSPLANTATION (2007)
Regulatory T-cell phenotype in association with large cell transformation of mycosis fungoides
Christian Hallermann et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Lack of suppressive CD4+CD25+FOXP3+T cells in advanced stages of primary cutaneous T-cell lymphoma
Machteld M. Tiemessen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Blockade of CTLA-4 on CD4+ CD25+ regulatory T cells abrogates their function in vivo
Simon Read et al.
JOURNAL OF IMMUNOLOGY (2006)
Sezary cell counts in erythrodermic cutaneous T-cell lymphoma: Implications for prognosis and staging
Eric C. Vonderheid et al.
LEUKEMIA & LYMPHOMA (2006)
The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology
David M. Sansom et al.
IMMUNOLOGICAL REVIEWS (2006)
Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas
C-D Klemke et al.
LEUKEMIA (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Tumor-infiltrating T lymphocytes: friends or foes?
P Yu et al.
LABORATORY INVESTIGATION (2006)
CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma
Rakhshandra Talpur et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Release of MICB molecules by tumor cells: Mechanism and soluble MICB in sera of cancer patients
Helmut Rainer Salih et al.
HUMAN IMMUNOLOGY (2006)
Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells
SM Chen et al.
INTERNATIONAL IMMUNOLOGY (2006)
Increased expression of CTLA-4 in malignant T cells from patients with mycosis fungoides - Cutaneous T-cell lymphoma
Henry K. Wong et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in Sezary syndrome patients
JD Bouaziz et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma
G Roncador et al.
LEUKEMIA (2005)
MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells costimulates pamidronate-activated γδ lymphocytes
S Girlanda et al.
CANCER RESEARCH (2005)
Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells
T Kohno et al.
CANCER SCIENCE (2005)
CCRIO is expressed in cutaneous T-cell lymphoma
M Notohainiprodjo et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Plastins: versatile modulators of actin organization in (patho)physiological cellular processes
V Delanote et al.
ACTA PHARMACOLOGICA SINICA (2005)
Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells
A Maeda et al.
JOURNAL OF IMMUNOLOGY (2005)
Immunopathogenesis and therapy of cutaneous T cell lymphoma
EJ Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells
Y Matsubara et al.
LEUKEMIA (2005)
Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells
CL Berger et al.
BLOOD (2005)
Circulating clonal CLA+ and CD4+T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7
M Sokolowska-Wojdyo et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells
E Carbone et al.
BLOOD (2005)
Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides
A Molina et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells
JD Coudert et al.
BLOOD (2005)
Expression of FOXP3 mRNA is not confined to CD4(+)CD25(+) T regulatory cells in humans
ME Morgan et al.
HUMAN IMMUNOLOGY (2005)
Clinicopathological features of cutaneous lesions of adult T-cell leukaemia/lymphoma
T Yamaguchi et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Naturally-occurring CD4+CD25+ immunoregulatory T cells:: central players in the arena of peripheral tolerance
CA Piccirillo et al.
SEMINARS IN IMMUNOLOGY (2004)
Cytolytic effector mechanisms and gene expression in autologous Graft-versus-Host disease: Distinct roles of perforin and fas ligand
Y Miura et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Treatment of advanced mycosis fungoides/Sezary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy
P Quaglino et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation
KE Herbert et al.
BONE MARROW TRANSPLANTATION (2004)
Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis
R van Doorn et al.
CANCER RESEARCH (2004)
Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: Implications for targeted therapy
D Jones et al.
CLINICAL CANCER RESEARCH (2004)
Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15
M Wysocka et al.
BLOOD (2004)
Expression of FoxP3, a key molecule in CD4+CD25+ regulatory T cells, in adult T-cell leukaemia/lymphoma cells
K Karube et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
H Yagi et al.
INTERNATIONAL IMMUNOLOGY (2004)
Prognostic factors in Sezary syndrome:: a study of 28 patients
P Foulc et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Cutting edge:: CD28 controls peripheral homeostasis of CD4+CD25+
QZ Tang et al.
JOURNAL OF IMMUNOLOGY (2003)
Roles of the NKG2D immunoreceptor and its ligands
DH Raulet
NATURE REVIEWS IMMUNOLOGY (2003)
Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells
T Maier et al.
BLOOD (2003)
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih et al.
BLOOD (2003)
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma
L Kari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen
D Soligo et al.
BONE MARROW TRANSPLANTATION (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Innate immune recognition by stimulatory immunoreceptors
A Diefenbach et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Sezary syndrome and related variants of classic cutaneous T-cell lymphoma. A descriptive and prognostic clinicopathologic study of 29 cases
RM Marti et al.
LEUKEMIA & LYMPHOMA (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Cytokine and chemokine profiles in autologous graft-versus-host disease (GVM):: interleukin 10 and interferon γ may be critical mediators for the development of autologous GVHD
Y Miura et al.
BLOOD (2002)
The use of anti-T-cell receptor-Vβ antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas
C Schwab et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?
E Vivier et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas
EC Vonderheid et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
CD28 function: A balance of costimulatory and regulatory signals
H Bour-Jordan et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2002)
Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sezary syndrome)
EC Vonderheid et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma
JJ Scarisbrick et al.
BLOOD (2001)
The relevance of the CD4+CD26-subset in the identification of circulating Sezary cells
MG Bernengo et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)